Health

Several corporates backed the blockchain technology developer in its latest round, boosting its valuation to $1bn. Valuations of blockchain tech companies have soared along with the interest in speculative assets classes inherently linked to the blockchain in recent times.

Smiths Medical and WuXi AppTec are exiting infusion pump developer Ivenix in an acquisition that could reach $240m, while AI software developer Syntiant raised $55m from investors including Renesas.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Several corporates helped hydrogen refuelling service H2 Mobility Deutschland collect $122m while enterprise optimisation software developer Skan.ai closed a $40m Dell-led series B round

GV, Optum, Children’s Medical Center Corporation and Blue Cross Blue Shield of Massachusetts returned to take the behavioural health provider’s overall funding past $200m.

Venture capital firm V-Bio Ventures has reached the final close of its second fund, with Vanden Avenue Commodities among the limited partners.

The neurological disease treatment developer took its funding to over $213m, completing a series C round led by SoftBank Vision Fund 2.

LetsGetChecked is moving into genomics with the acquisition of the genetic testing technology provider, allowing Lilly Ventures Asia and Jiangsu Simcere to exit.

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

VIB-backed venture capital firm V-Bio Ventures has reached the final close of its second fund and hired Shelley Margetson as managing partner.